Low Papanicolaou Smear Screening Rate of Women with HIV Infection: a Nationwide Population-based Study in Taiwan, 2000-2010

Overview

Journal J Womens Health (Larchmt)

Specialty Gynecology & Obstetrics

Date 2013 Sep 3

PMID 23992102

Citations 2

Authors

Yen-Chin Chen

Hsiao-Ying Liu

Chung-Yi Li

Nan-Yao Lee

Wen-Chien Ko

Cheng-Yang Chou

Tung-Han Hsieh

Nai-Ying Ko

Affiliations

Soon will be listed here.

Abstract

Background: Women infected by human immunodeficiency virus (HIV) have a higher risk of contracting cervical cancer. Recent guidelines recommend that all HIV-positive women should receive two Pap smears in the first year after their HIV diagnosis.

Methods: This was a population-based cohort study, and the National Health Insurance Research Database (NHIRD) in Taiwan was used to estimate the Pap smear screening rate for 1449 HIV-infected women aged 18 years and over from 2000 to 2010. A multiple logistic regression analysis was used to identify factors associated with HIV-infected women who had received Pap smears.

Results: Of 1449 women, 618 (43%) women received at least one Pap smear. Only 14.7% of the HIV-infected women received Pap smears within one year after being diagnosed with HIV. A logistic regression analysis showed that the factors associated with receiving at least one Pap smear after HIV diagnosis were increasing age (AOR 1.04, 95% CI 1.03-1.05), high monthly income (AOR 1.83, 95% CI 1.51-2.23), any history of antiretroviral therapy (AOR 1.78, 95% CI 1.38-2.29), retention in HIV care (AOR 1.36, 95% CI 1.04-1.77), a history of sexually transmitted diseases (AOR 1.96, 95% CI 1.50-2.56), and any history of treatment for opportunistic infections (AOR 2.46, 95% CI 1.91-3.16).

Conclusions: A great need exists to develop strategies for promoting receipt of Pap smear screening services that specifically target severely disadvantaged women with HIV, particularly younger, lower income women and those in an asymptomatic phase.

Citing Articles

Knowledge, Attitudes, and Practices Regarding Cervical Cancer Screening among HIV-infected Women at Srinagarind Hospital: A Cross-Sectional Study.

Songsiriphan A, Salang L, Somboonpha W, Eamudomkarn N, Nhokaew W, Kuchaisit C Asian Pac J Cancer Prev. 2020; 21(10):2979-2986.

PMID: 33112557 PMC: 7798176. DOI: 10.31557/APJCP.2020.21.10.2979.

Number of Primary Care Visits Associated with Screening for Cervical Dysplasia among Women with HIV Infection in Harris County, Texas, United States of America.

Dailey Garnes N, DSouza G, Chiao E HIV Adv Res Dev. 2016; 1(2).

PMID: 27500276 PMC: 4974513.

References

Dal Maso L, Franceschi S, Lise M, Sassoli de Bianchi P, Polesel J, Ghinelli F . Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010; 10:310. PMC: 2904281. DOI: 10.1186/1471-2407-10-310. View

Oster A, Sullivan P, Blair J . Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr. 2009; 51(4):430-6. DOI: 10.1097/QAI.0b013e3181acb64a. View

Ibrahim F, Schembri G, Taha H, Ariyanayagam S, Dhar J . Cervical surveillance in HIV-positive women: a genitourinary medicine clinic experience. J Fam Plann Reprod Health Care. 2009; 35(2):101-3. DOI: 10.1783/147118909787931735. View

Keiser O, Martinez de Tejada B, Wunder D, Chapuis-Taillard C, Zellweger C, Zinkernagel A . Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2006; 43(5):550-5. DOI: 10.1097/01.qai.0000245884.66509.7a. View

Andrasik M, Rose R, Pereira D, Antoni M . Barriers to cervical cancer screening among low-income HIV-positive African American women. J Health Care Poor Underserved. 2008; 19(3):912-25. DOI: 10.1353/hpu.0.0037. View

Baranoski A, Horsburgh C, Cupples L, Aschengrau A, Stier E . Risk factors for nonadherence with Pap testing in HIV-infected women. J Womens Health (Larchmt). 2011; 20(11):1635-43. PMC: 3216072. DOI: 10.1089/jwh.2010.2465. View

Chung S, Pfeiffer S, Lin H . Lower utilization of cervical cancer screening by nurses in Taiwan: a nationwide population-based study. Prev Med. 2011; 53(1-2):82-4. DOI: 10.1016/j.ypmed.2011.05.002. View

Logan J, Khambaty M, DSouza K, Menezes L . Cervical cancer screening among HIV-infected women in a health department setting. AIDS Patient Care STDS. 2010; 24(8):471-5. DOI: 10.1089/apc.2009.0295. View

Kaplan J, Benson C, Holmes K, Brooks J, Pau A, Masur H . Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009; 58(RR-4):1-207. View

10.

Anderson J, Paramsothy P, Heilig C, Jamieson D, Shah K, Duerr A . Accuracy of Papanicolaou test among HIV-infected women. Clin Infect Dis. 2006; 42(4):562-8. DOI: 10.1086/499357. View

11.

Yang C, Yang S, Shen M, Kuo H . The changing epidemiology of prevalent diagnosed HIV infections in Taiwan, 1984-2005. Int J Drug Policy. 2008; 19(4):317-23. DOI: 10.1016/j.drugpo.2006.11.016. View

12.

Maiman M, Fruchter R, Clark M, Arrastia C, Matthews R, Gates E . Cervical cancer as an AIDS-defining illness. Obstet Gynecol. 1997; 89(1):76-80. DOI: 10.1016/s0029-7844(96)00378-x. View

13.

Chen M, Wu M, Yang J, Chao K, Yang Y, Ho H . Increased frequency of genital human papillomavirus infection in human immunodeficiency virus-seropositive Taiwanese women. J Formos Med Assoc. 2005; 104(1):34-8. View

14.

Anastos K, Hoover D, Burk R, Cajigas A, Shi Q, Singh D . Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One. 2010; 5(10):e13525. PMC: 2958122. DOI: 10.1371/journal.pone.0013525. View

15.

Frisch M, Biggar R, Engels E, Goedert J . Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001; 285(13):1736-45. DOI: 10.1001/jama.285.13.1736. View

16.

Huang K, Tsai W, Kung P . The use of Pap smear and its influencing factors among women with disabilities in Taiwan. Res Dev Disabil. 2011; 33(2):307-14. DOI: 10.1016/j.ridd.2011.09.016. View

17.

Lee T, Fu L, Fleming P . Using focus groups to investigate the educational needs of female injecting heroin users in Taiwan in relation to HIV/AIDS prevention. Health Educ Res. 2005; 21(1):55-65. DOI: 10.1093/her/cyh041. View

18.

Dombrowski J, Kent J, Buskin S, Stekler J, Golden M . Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS. 2011; 26(1):77-86. PMC: 3434867. DOI: 10.1097/QAD.0b013e32834dcee9. View

19.

Lu M, Moritz S, Lorenzetti D, Sykes L, Straus S, Quan H . A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health. 2012; 12:413. PMC: 3488494. DOI: 10.1186/1471-2458-12-413. View

20.

Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D . Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. J Womens Health (Larchmt). 2010; 19(4):709-12. PMC: 2867552. DOI: 10.1089/jwh.2009.1412. View